(Q38069873)

28 August 2017

1 reference

title

Bacteriocins - a viable alternative to antibiotics? (English)

1 reference

28 August 2017

0 references

1

1 reference

28 August 2017

3

1 reference

28 August 2017

R Paul Ross

2

1 reference

28 August 2017

language of work or name

English

0 references

publication date

24 December 2012

1 reference

Nature Reviews Microbiology

28 August 2017

published in

1 reference

28 August 2017

volume

11

1 reference

28 August 2017

issue

2

1 reference

28 August 2017

page(s)

95-105

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro2937

28 August 2017

exact match

0 references

cites work

Effective antibacterials: at what cost? The economics of antibacterial resistance and its control

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Fix the antibiotics pipeline.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Antibiotic overuse: Stop the killing of beneficial bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Shifting the balance: antibiotic effects on host-microbiota mutualism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Plant-derived antimicrobial compounds: alternatives to antibiotics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

RNA therapeutics: beyond RNA interference and antisense oligonucleotides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Probiotics in perspective.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Overview on the recent study of antimicrobial peptides: origins, functions, relative mechanisms and application

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Bacteriocins: developing innate immunity for food

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Generation of an actagardine A variant library through saturation mutagenesis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Bacteriocins to control Campylobacter spp. in poultry--A review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Bacteriocin as weapons in the marine animal-associated bacteria warfare: inventory and potential applications as an aquaculture probiotic.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Discovery of medically significant lantibiotics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Thiazomycins, thiazolyl peptide antibiotics from Amycolatopsis fastidiosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Isolation, structure, and antibacterial activity of philipimycin, a thiazolyl peptide discovered from Actinoplanes philippinensis MA7347.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Antibacterial evaluations of thiazomycin- a potent thiazolyl peptide antibiotic from Amycolatopsis fastidiosa

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Ribosomally synthesized thiopeptide antibiotics targeting elongation factor Tu.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Mechanism of action of and mechanism of reduced susceptibility to the novel anti-Clostridium difficile compound LFF571

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The spectrum of antimicrobial activity of the bacteriocin subtilosin A

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Elucidation of the Molecular Mechanisms of Action of the Natural Antimicrobial Peptide Subtilosin Against the Bacterial Vaginosis-associated Pathogen Gardnerella vaginalis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Identification and characterization of the structural and transporter genes for, and the chemical and biological properties of, sublancin 168, a novel lantibiotic produced by Bacillus subtilis 168.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Metagenome mining reveals polytheonamides as posttranslationally modified ribosomal peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti-VRE activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The continuing story of class IIa bacteriocins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

AS-48 bacteriocin: close to perfection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Identification, characterization, and recombinant expression of epidermicin NI01, a novel unmodified bacteriocin produced by Staphylococcus epidermidis that displays potent activity against Staphylococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Structure and mode of action of microcin 7, an antibacterial peptide produced by Escherichia coli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The iron-siderophore transporter FhuA is the receptor for the antimicrobial peptide microcin J25: role of the microcin Val11-Pro16 beta-hairpin region in the recognition mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Synthetic peptides derived from the sequence of a lasso peptide microcin J25 show antibacterial activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

A new family of low molecular weight antibiotics from enterobacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The leader peptide of colicin V shares consensus sequences with leader peptides that are common among peptide bacteriocins produced by gram-positive bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Genetic analysis and complete primary structure of microcin L.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Siderophore peptide, a new type of post-translationally modified antibacterial peptide with potent activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Isolation and characterization of two members of the siderophore-microcin family, microcins M and H47

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Dual antibacterial mechanisms of nisin Z against Gram-positive and Gram-negative bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Inactivating methicillin-resistant Staphylococcus aureus and other pathogens by use of bacteriocins OR-7 and E 50-52.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Sensitization of microcin J25-resistant strains by a membrane-permeabilizing peptide.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The natural antimicrobial peptide subtilosin acts synergistically with glycerol monolaurate, lauric arginate, and ε-poly-L-lysine against bacterial vaginosis-associated pathogens but not human lactobacilli.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Bacteriocins Pep5 and epidermin inhibit Staphylococcus epidermidis adhesion to catheters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Differential release of lipoteichoic and teichoic acids from Streptococcus pneumoniae as a result of exposure to beta-lactam antibiotics, rifamycins, trovafloxacin, and quinupristin-dalfopristin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Nisin F-loaded brushite bone cement prevented the growth of Staphylococcus aureus in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Nisin F in the treatment of respiratory tract infections caused by Staphylococcus aureus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The ability of nisin F to control Staphylococcus aureus infection in the peritoneal cavity, as studied in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

In vivo activity of mutacin B-Ny266.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

A novel lantibiotic acting on bacterial cell wall synthesis produced by the uncommon actinomycete Planomonospora sp.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Efficacy of LFF571 in a hamster model of Clostridium difficile infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

In vivo activities of recombinant divercin V41 and its structural variants against Listeria monocytogenes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Enterocin CRL35 inhibits Listeria monocytogenes in a murine model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Antimycobacterial activity of bacteriocins and their complexes with liposomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Efficacy of microcin J25 in biomatrices and in a mouse model of Salmonella infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Cyanobactins-ribosomal cyclic peptides produced by cyanobacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

In vitro assessment of the cytotoxicity of nisin, pediocin, and selected colicins on simian virus 40-transfected human colon and Vero monkey kidney cells with trypan blue staining viability assays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Interactions between two carnobacteriocins Cbn BM1 and Cbn B2 from Carnobacterium maltaromaticum CP5 on target bacteria and Caco-2 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Effect of broad- and narrow-spectrum antimicrobials on Clostridium difficile and microbial diversity in a model of the distal colon.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

In vivo study on the effectiveness of pediocin PA-1 and Pediococcus acidilactici UL5 at inhibiting Listeria monocytogenes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

In vitro inhibition activity of nisin A, nisin Z, pediocin PA-1 and antibiotics against common intestinal bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Pediocin PA-1 and a pediocin producing Lactobacillus plantarum strain do not change the HMA rat microbiota.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Isolation of the Bacillus subtilis antimicrobial peptide subtilosin from the dairy product-derived Bacillus amyloliquefaciens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Bacteriocin production: a probiotic trait?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Production of bioactive substances by intestinal bacteria as a basis for explaining probiotic mechanisms: bacteriocins and conjugated linoleic acid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Prebiotics enhance survival and prolong the retention period of specific probiotic inocula in an in vivo murine model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Survival and retention of the probiotic Lactobacillus casei LAFTI L26 in the gastrointestinal tract of the mouse.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica Serovar Typhimurium.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Predominance of a bacteriocin-producing Lactobacillus salivarius component of a five-strain probiotic in the porcine ileum and effects on host immune phenotype

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Influence of adhesion and bacteriocin production by Lactobacillus salivarius on the intestinal epithelial cell transcriptional response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Capacity of human nisin- and pediocin-producing lactic Acid bacteria to reduce intestinal colonization by vancomycin-resistant enterococci.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Identification and characterization of microcin S, a new antibacterial peptide produced by probiotic Escherichia coli G3/10

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Modification of an effector strain for replacement therapy of dental caries to enable clinical safety trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Genetically modified Streptococcus mutans for the prevention of dental caries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Gut Microbiota in Health and Disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Identification of genetic loci in Lactobacillus plantarum that modulate the immune response of dendritic cells using comparative genome hybridization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Identification of Lactobacillus plantarum genes modulating the cytokine response of human peripheral blood mononuclear cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

In vitro mutasynthesis of lantibiotic analogues containing nonproteinogenic amino acids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The dawning of a 'Golden era' in lantibiotic bioengineering.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The Synthesis of Active and Stable Diaminopimelate Analogues of the Lantibiotic Peptide Lactocin S

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Comparative in vitro activities of LFF571 against Clostridium difficile and 630 other intestinal strains of aerobic and anaerobic bacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

In vitro characterization of DNA gyrase inhibition by microcin B17 analogs with altered bisheterocyclic sites

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Synthetic microcin C analogs targeting different aminoacyl-tRNA synthetases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Development of Class IIa Bacteriocins as Therapeutic Agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

A C-terminal disulfide bridge in pediocin-like bacteriocins renders bacteriocin activity less temperature dependent and is a major determinant of the antimicrobial spectrum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Development of innovative pediocin PA-1 by DNA shuffling among class IIa bacteriocins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Mutational analysis of the role of charged residues in target-cell binding, potency and specificity of the pediocin-like bacteriocin sakacin P.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Genome mining for ribosomally synthesized natural products

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Thirteen posttranslational modifications convert a 14-residue peptide into the antibiotic thiocillin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

ThioFinder: a web-based tool for the identification of thiopeptide gene clusters in DNA sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Cysteine S-glycosylation, a new post-translational modification found in glycopeptide bacteriocins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Genome mining demonstrates the widespread occurrence of gene clusters encoding bacteriocins in cyanobacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Target recognition, resistance, immunity and genome mining of class II bacteriocins from Gram-positive bacteria.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Lantibiotics from Geobacillus thermodenitrificans.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Production of a class II two-component lantibiotic of Streptococcus pneumoniae using the class I nisin synthetic machinery and leader sequence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Lantibiotics: mode of action, biosynthesis and bioengineering

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Expanding role of lipid II as a target for lantibiotics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

A comparison of the activities of lacticin 3147 and nisin against drug-resistant Staphylococcus aureus and Enterococcus species.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Common mechanisms of target cell recognition and immunity for class II bacteriocins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Parasitism of iron-siderophore receptors of Escherichia coli by the siderophore-peptide microcin E492m and its unmodified counterpart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The large mechanosensitive channel MscL determines bacterial susceptibility to the bacteriocin sublancin 168

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The action of the bacterial toxin, microcin B17, on DNA gyrase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The structure and biological aspects of peptide antibiotic microcin J25.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The Escherichia coli Yej transporter is required for the uptake of translation inhibitor microcin C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Escherichia coli peptidase A, B, or N can process translation inhibitor microcin C.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Aspartyl-tRNA synthetase is the target of peptide nucleotide antibiotic Microcin C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

31 March 2020

Thiopeptide antibiotics

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Transcriptome analysis reveals mechanisms by which Lactococcus lactis acquires nisin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Mechanisms of resistance to bacteriocins targeting the mannose phosphotransferase system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Mutations of bacterial RNA polymerase leading to resistance to microcin j25.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Molecular determinants of microbial resistance to thiopeptide antibiotics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Cross-immunity and immune mimicry as mechanisms of resistance to the lantibiotic lacticin 3147

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Novel mechanism for nisin resistance via proteolytic degradation of nisin by the nisin resistance protein NSR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Structural and Functional Characterization of Microcin C Resistance Peptidase MccF from Bacillus anthracis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Identification of Bacillus subtilis sigma-dependent genes that provide intrinsic resistance to antimicrobial compounds produced by Bacilli

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

To protect peptide pharmaceuticals against peptidases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Sources of novel antibiotics--aside the common roads

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Microcins, gene-encoded antibacterial peptides from enterobacteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Lantibiotics: peptides of diverse structure and function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Thiazole/oxazole-modified microcins: complex natural products from ribosomal templates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Recent advances in thiopeptide antibiotic biosynthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

The glucagon receptor antagonist BI-32169 constitutes a new class of lasso peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Genome mining for radical SAM protein determinants reveals multiple sactibiotic-like gene clusters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Structure and biosynthesis of the antibiotic bottromycin D

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Synthesis of the bacteriocin glycopeptide sublancin 168 and S-glycosylated variants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Sublancin is not a lantibiotic but an S-linked glycopeptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Microcin C: biosynthesis and mechanisms of bacterial resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Highly diverse cyanobactins in strains of the genus Anabaena.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO2937

Comparative studies of class IIa bacteriocins of lactic acid bacteria

31 March 2020

1 reference

12 December 2020

Comparison of the activity spectra against pathogens of bacterial strains producing a mutacin or a lantibiotic

1 reference

12 December 2020

Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature

1 reference

12 December 2020

NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW

1 reference

12 December 2020

Type 1 pili are not necessary for colonization of the streptomycin-treated mouse large intestine by type 1-piliated Escherichia coli F-18 and E. coli K-12.

1 reference

12 December 2020

Prevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.

1 reference

12 December 2020

Combined effect of synthetic enterocin CRL35 with cell wall, membrane-acting antibiotics and muranolytic enzymes against Listeria cells

1 reference

12 December 2020

The impact of antibiotics on the gut microbiota as revealed by high throughput DNA sequencing

1 reference

12 December 2020

Activity of nisin against Streptococcus pneumoniae, in vitro, and in a mouse infection model

1 reference

12 December 2020

Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.

1 reference

12 December 2020

Antibiotic treatment for Clostridium difficile -associated diarrhea in adults

1 reference

12 December 2020

Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity

1 reference

12 December 2020

Activity of the thiopeptide antibiotic nosiheptide against contemporary strains of methicillin-resistant Staphylococcus aureus

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRMICRO2937

1 reference

Dimensions Publication ID

28 August 2017

1036017430

0 references

1 reference